Anthony J. Polverino - Aug 31, 2021 Form 4 Insider Report for Zymeworks Inc. (ZYME)

Role
Chief Scientific Officer
Signature
/s/ Daniel Dex, Attorney-in-Fact
Stock symbol
ZYME
Transactions as of
Aug 31, 2021
Transactions value $
$73,500
Form type
4
Date filed
9/2/2021, 08:00 PM
Previous filing
Jul 8, 2021
Next filing
Dec 10, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ZYME Common Shares Options Exercise $73.5K +4.9K +15.59% $15.00* 36.3K Aug 31, 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ZYME Stock Option (Right to Buy) Options Exercise $0 -4.9K -5.94% $0.00 77.6K Aug 31, 2021 Common Shares 4.9K $15.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Stock options vest as follows: (i) 25% of underlying shares on first anniversary of grant date of December 12, 2018, and (ii) remainder of underlying shares in 36 equal monthly installments on last day of month following first anniversary of grant date.